Table 1.
Clinical characteristics of GCMN and normal skin samples
| Sample ID | Age, yr | Gender | Location | Experiment |
|---|---|---|---|---|
|
Normal |
|
|||
| Normal 1* |
8 |
Male |
Face |
LC-MS |
| Normal 2* |
5 |
Female |
Face |
LC-MS |
| Normal 3* |
6 |
Female |
Face |
LC-MS |
| Normal 4 |
14 |
Female |
Forehead |
Western blot |
| Normal 5 |
11 |
Female |
Face |
Western blot |
| Normal 6 |
19 |
Female |
Forehead |
Western blot |
| Normal 7 |
36 |
Female |
Face |
Western blot |
| Normal 8 |
18 |
Female |
Face |
Western blot |
| Normal 9 |
21 |
Female |
Face |
Western blot |
| Normal 10 |
40 |
Female |
Face |
Western blot |
|
GCMN |
|
|||
| GCMN 1 |
8 |
Male |
Face |
LC-MS |
| GCMN 2 |
5 |
Female |
Face |
LC-MS |
| GCMN 3 |
6 |
Female |
Face |
LC-MS |
| GCMN 4 |
8 |
Male |
Forehead |
Western blot |
| GCMN 5 |
6 |
Female |
Abdomen |
Western blot |
| GCMN 6 |
3 |
Female |
Left leg |
Western blot |
| GCMN 7 |
3 |
Male |
Face |
Western blot |
| GCMN 8 |
6 |
Female |
Forehead |
Western blot |
| GCMN 9 |
7 |
Male |
Abdomen |
Western blot |
| GCMN 10 | 6 | Female | Head | Western blot |
* Normal skin samples excised from GCMN patient ID 1, 2, 3.